Comments
Shares of Dr Reddy's Laboratories on Tuesday tumbled over 10 per cent after the company reported a 36 per cent decline in consolidated net profit for the quarter ended June 30, 2021.
The company's stock plummeted 10.44 per cent to close at ₹4,844.35 on the BSE.
During the day, it tumbled 11.61 per cent to ₹4,781.
On the NSE, it plunged 10.31 per cent to close at ₹4,853.20.
Dr Reddy's Laboratories on Tuesday reported a 36 per cent decline in consolidated net profit at ₹380.4 crore for the quarter ended June 30, 2021, on account of higher expenses.
The pharma major had posted a net profit of ₹594.6 crore in the corresponding period a year ago.
Total income during the June quarter of the current fiscal stood at ₹5,053 crore, up 12 per cent as against ₹4,513.6 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.